Submit Deal

TAKEDA VENTURES

Summary

TVI's mission is to identify, help create and support the development of therapeutic innovation.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 2.54 B

Avg. Deal Size£ 423 M

Market Context

Senior Management

Christophe Weber
President and CEO
Milano Furuta
Chairman
Marcello Agosti
Global Business Development Officer

Sort

05 Nov 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

09 Nov 2020|United States|Pharmaceuticals

Target: EMENDO BIOTHERAPEUTICS

Bidder: ANGES

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 111 M

Value

24 Feb 2021|United States|Biotechnology

Target: XILIO THERAPEUTICS

Bidder: RIVERVEST VENTURE PARTNERS

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 64 M

Value

14 Apr 2022|United States|Pharmaceuticals

Target: BE BIO

Bidder: ATLAS VENTURE LP

9 Service Providers

3 Target | 6 Bidder

10 Dealmakers

3 Target | 7 Bidder

£ 99 M

Value

07 Feb 2022|United States|Medical Equipment

Target: KONEKSA HEALTH

Bidder: SPRING MOUNTAIN CAPITAL

5 Service Providers

3 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 37 M

Value

05 Jan 2023|United States|Biotechnology

Target: ENSOMA

Bidder: ARIX BIOSCIENCE

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 108 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy